LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,421,000 | +53.8% | 30,590 | 0.0% | 0.13% | +28.7% |
| Q1 2020 | $2,225,000 | -47.9% | 30,590 | -25.3% | 0.10% | -37.7% |
| Q4 2019 | $4,271,000 | -2.6% | 40,955 | -7.0% | 0.16% | -15.2% |
| Q3 2019 | $4,385,000 | -12.8% | 44,055 | 0.0% | 0.19% | -6.8% |
| Q2 2019 | $5,029,000 | +33.8% | 44,055 | +47.4% | 0.20% | +34.0% |
| Q1 2019 | $3,758,000 | +4.7% | 29,895 | +13.0% | 0.15% | -0.6% |
| Q4 2018 | $3,589,000 | +46.3% | 26,450 | +195.9% | 0.15% | +73.0% |
| Q3 2018 | $2,454,000 | -33.4% | 8,940 | -87.1% | 0.09% | -48.3% |
| Q4 2014 | $3,682,000 | +13.2% | 69,200 | 0.0% | 0.17% | +13.2% |
| Q3 2014 | $3,252,000 | – | 69,200 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |